Quantum BioPharma Ltd.
QNTM
$9.70
-$1.71-14.99%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -83.61% | -54.08% | 69.31% | 104.90% | 51.04% |
| Total Receivables | -58.57% | -50.75% | -50.03% | -48.67% | 56.65% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -62.03% | 226.23% | -31.59% | -65.76% | -50.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 11,026.50% | -- | 2,652.29% | 2,791.21% | -66.11% |
| Total Current Assets | -32.51% | 3.21% | 8.06% | 8.73% | 49.72% |
|
|
|||||
| Total Current Assets | -32.51% | 3.21% | 8.06% | 8.73% | 49.72% |
| Net Property, Plant & Equipment | 38.97% | 212.18% | 4.00% | 8.31% | 1.10% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -8.35% | -8.17% | -8.01% | -7.88% | -7.72% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -25.61% | 0.33% | -3.66% | -2.03% | 0.45% |
|
|
|||||
| Total Accounts Payable | 93.35% | -48.07% | -49.67% | 0.44% | -49.36% |
| Total Accrued Expenses | -24.53% | 61.82% | 55.27% | 16.01% | 88.89% |
| Short-term Debt | 557.34% | 215.87% | 81.35% | 105.99% | 0.00% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 702.48% | 3,239.58% | 704.60% | 432.04% | 16.37% |
| Total Finance Division Other Current Liabilities | 1,700.00% | -- | 83,741.25% | 4,666.77% | -99.92% |
| Total Other Current Liabilities | 1,700.00% | -- | 83,741.25% | 4,666.77% | -99.92% |
| Total Current Liabilities | 80.56% | 162.64% | 163.62% | 46.29% | -12.25% |
|
|
|||||
| Total Current Liabilities | 80.56% | 162.64% | 163.62% | 46.29% | -12.25% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 557.34% | 215.87% | 81.35% | 105.99% | 0.00% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 80.56% | 162.64% | 163.62% | 46.29% | -12.25% |
|
|
|||||
| Common Stock & APIC | 12.43% | 12.36% | 9.33% | 8.06% | 7.29% |
| Retained Earnings | -17.10% | -16.58% | -13.06% | -8.99% | -6.55% |
| Treasury Stock & Other | -53.90% | -54.00% | -45.80% | -34.77% | -16.33% |
| Total Common Equity | -46.89% | -65.65% | -52.35% | -13.27% | 9.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -46.89% | -65.65% | -52.35% | -13.27% | 9.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -21.29% | -127.05% | -133.42% | -217.65% | -955.08% |
| Total Equity | -51.08% | -79.94% | -60.67% | -19.13% | 4.06% |
|
|
|||||